List of insiders holdings for Sierra Oncology Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Topper James N Director 10% Owner | 2017-02-16 17:11:02 | 0 8,112,121 | 8,112,121 | Form 4 |
| ORBIMED ADVISORS LLC ISALY SAMUEL D OrbiMed Private Investments V LP Director | 2022-03-15 16:30:23 | 3,044,753 0 | 3,044,753 | Form 13D |
| ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Global Healthcare GP LLC ORBIMED CAPITAL LLC Director 10% Owner | 2022-03-15 16:30:23 | 3,044,753 0 | 3,044,753 | Form 13D |
| CHA ALBERT Director | 2015-07-21 18:59:59 | 0 2,547,241 | 2,547,241 | Form 4 |
| Richardson Joshua Director 10% Owner | 2022-02-02 21:24:03 | 0 2,139,771 | 2,139,771 | Form 4 |
| Thompson Peter A. Director | 2015-07-21 19:03:41 | 0 2,079,108 | 2,079,108 | Form 4 |
| Vitangcol Alvin Director | 2015-07-21 19:05:35 | 0 1,819,959 | 1,819,959 | Form 4 |
| Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G Longitude Prime Partners LLC Longitude Prime Fund L.P. 10% Owner | 2022-05-06 16:33:35 | 1,485,140 0 | 1,485,140 | Form 13D |
| Frazier Healthcare VI L.P. FHM VI L.P. FHM VI L.L.C. Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. FRAZIER ALAN D Naini Nader J Every Nathan R Heron Patrick J 10% Owner | 2022-01-28 13:39:59 | 1,264,861 0 | 1,264,861 | Form 13G |
| Glover Nicholas CEO and President | 2020-02-27 16:14:28 | 359,158 0 | 359,158 | Form 4 |
| You Angie Chief Bus. & Strat. Officer | 2018-03-07 17:57:32 | 180,360 0 | 180,360 | Form 4 |
| Rodigueza Wendi Chief Scientific Officer | 2016-01-22 16:55:33 | 156,276 0 | 156,276 | Form 4 |
| Hassig Christian Chief Scientific Officer | 2019-03-05 17:27:21 | 155,000 0 | 155,000 | Form 4 |
| Anderson Keith Edward SVP, Technical Operations | 2015-12-02 18:34:21 | 100,000 0 | 100,000 | Form 4 |
| Chapman Wendy SVP Clinical Operations | 2016-03-24 17:17:58 | 76,248 0 | 76,248 | Form 4 |
| Lovejoy Chandra D SVP of Reg. Affairs & Quality | 2016-03-10 17:12:26 | 31,000 0 | 31,000 | Form 4 |
| Parfet Donald R Director | 2019-06-12 17:54:11 | 30,000 0 | 30,000 | Form 4 |
| ONETTO NICOLE Director | 2019-06-12 17:52:40 | 30,000 0 | 30,000 | Form 4 |
| Nguyen Tran Director | 2019-06-12 17:50:51 | 30,000 0 | 30,000 | Form 4 |
| ESTES DANIEL Director | 2019-06-12 17:48:58 | 30,000 0 | 30,000 | Form 4 |
| Messmann Richard A Chief Medical Officer | 2016-03-10 17:13:58 | 25,000 0 | 25,000 | Form 4 |
| Thomson Christina General Counsel | 2021-03-17 21:18:07 | 12,900 0 | 12,900 | Form 4 |
| Kowalski Mark Chief, Research & Early Dev | 2022-01-28 18:34:15 | 12,250 0 | 12,250 | Form 4 |
| Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital IX LLC Vivo Capital Fund IX L.P. VIVO VENTURES VII LLC Vivo Ventures Fund VII L.P. Vivo Ventures VII Affiliates Fund L.P. Director 10% Owner | 2022-07-05 17:06:15 | 0 0 | 0 | Form 13G |
| ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC OrbiMed Capital GP VII LLC Director 10% Owner | 2022-07-01 16:50:05 | 0 0 | 0 | Form 4 |
| Ashiya Mona Director 10% Owner | 2022-07-01 16:46:16 | 0 0 | 0 | Form 4 |
| Aggarwal Gaurav Director | 2022-07-01 16:45:08 | 0 0 | 0 | Form 4 |
| Sinclair Andrew Director | 2022-07-01 16:44:37 | 0 0 | 0 | Form 4 |
| Klencke Barbara Chief Medical Officer | 2022-07-01 16:43:55 | 0 0 | 0 | Form 4 |
| Jagpal Sukhi Chief Financial Officer | 2022-07-01 16:42:46 | 0 0 | 0 | Form 4 |
| Pelzer Robert Director | 2022-07-01 16:41:11 | 0 0 | 0 | Form 4 |
| Cooper Jeffrey H Director | 2022-07-01 16:39:59 | 0 0 | 0 | Form 4 |
| Allen Andrew R Director 10% Owner | 2022-07-01 16:38:35 | 0 0 | 0 | Form 4 |
| Collard Craig A Director | 2022-07-01 16:37:01 | 0 0 | 0 | Form 4 |
| DILLY STEPHEN GEORGE CEO and President | 2022-07-01 16:35:51 | 0 0 | 0 | Form 4 |
| Thomson Mary Christina General Counsel | 2022-07-01 16:34:07 | 0 0 | 0 | Form 4 |
| Turner William D. Chief Reg & Tech Ops Officer | 2022-07-01 16:32:23 | 0 0 | 0 | Form 4 |
| Norrett Kevin Chief Business Officer | 2022-07-01 16:28:58 | 0 0 | 0 | Form 4 |
| Oliger Christy J. Director | 2022-07-01 16:27:25 | 0 0 | 0 | Form 4 |
| Erbez Georgia Director | 2022-07-01 16:25:41 | 0 0 | 0 | Form 4 |
| Abingworth LLP 10% Owner | 2022-07-11 16:30:36 | 0 0 | 0 | Form 13D |
| Vivo Opportunity LLC Vivo Opportunity Fund L.P. Vivo Capital IX LLC Vivo Capital Fund IX L.P. VIVO VENTURES VII LLC Vivo Ventures Fund VII L.P. Vivo Ventures VII Affiliates Fund L.P. 10% Owner | 2022-07-05 17:06:15 | 0 0 | 0 | Form 13G |